This stimulatory effect of IL-17 on self-renewal of ovarian cancer stem cells seems to involve NF-kB and p38 MAPK: in line with this observation, these effects were blocked by NF-kB and p38 MAPK inhibitors [247]. This evidence concerns the gene NFKB1 and ovarian cancer.